Blue Earth Therapeutics

Blue Earth Therapeutics is a clinical-stage company dedicated to advancing next-generation targeted radiotherapies to treat cancer patients. With established management expertise in radiopharmaceuticals and oncology drug development, as well as biotech startup experience, the company aims to innovate and improve existing technologies while rapidly advancing new targeted therapies for serious diseases. Blue Earth Therapeutics has an emerging pipeline, initially focused on prostate cancer, with plans to expand into other disease areas within oncology.